Novartis AG Apologizes For Not Disclosing Side-Effects Of Leukemia Drugs Sooner

(Reuters) - The Japanese unit of Novartis AG apologized on Thursday for failing to report to authorities in a timely manner side-effects of its leukemia drugs, in the company's latest scandal in the country.

Novartis Pharma KK, the Swiss drugmaker's wholly owned local subsidiary, said Japan's Ministry of Health, Labour and Welfare ordered the company to improve its practices after the company did not report side-effects of its Gleevec and Tasigna leukemia treatments until around April.

Help employers find you! Check out all the jobs and post your resume.